California State Teachers Retirement System Arbutus Biopharma Corp Transaction History

California State Teachers Retirement System

$80.4 Billion
Q2 2024

A detailed history of California State Teachers Retirement System transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, California State Teachers Retirement System holds 10,107 shares of ABUS stock, worth $39,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,107

Previous 12,737 20.65%

Holding current value

$39,821

Previous $32,000 3.13%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.52 - $3.63 $6,627 - $9,546	-2,630 Reduced 20.65%	10,107 $31,000
Q1 2024 May 15, 2024	SELL	$2.26 - $2.92 $18,344 - $23,701	-8,117 Reduced 38.92%	12,737 $32,000
Q4 2023 Feb 13, 2024	SELL	$1.69 - $2.54 $11,301 - $16,984	-6,687 Reduced 24.28%	20,854 $52,000
Q3 2023 Nov 14, 2023	SELL	$1.9 - $2.27 $26,562 - $31,734	-13,980 Reduced 33.67%	27,541 $55,000
Q2 2023 Aug 21, 2023	SELL	$2.24 - $3.06 $1,610 - $2,200	-719 Reduced 1.7%	41,521 $95,000
Q1 2023 May 09, 2023	SELL	$2.23 - $3.1 $8,750 - $12,164	-3,924 Reduced 8.5%	42,240 $127,000
Q4 2022 Feb 14, 2023	BUY	$1.91 - $2.85 $6,757 - $10,083	3,538 Added 8.3%	46,164 $107,000
Q3 2022 Nov 18, 2022	SELL	$1.88 - $2.88 $6,681 - $10,235	-3,554 Reduced 7.7%	42,626 $81,000
Q2 2022 Aug 15, 2022	BUY	$1.98 - $3.17 $14,800 - $23,695	7,475 Added 19.31%	46,180 $125,000
Q1 2022 May 16, 2022	SELL	$2.42 - $3.98 $11,824 - $19,446	-4,886 Reduced 11.21%	38,705 $115,000
Q4 2021 Feb 15, 2022	BUY	$3.11 - $4.61 $4,441 - $6,583	1,428 Added 3.39%	43,591 $170,000
Q3 2021 Nov 15, 2021	SELL	$2.65 - $4.62 $174,714 - $304,596	-65,930 Reduced 60.99%	42,163 $181,000
Q2 2021 Aug 16, 2021	BUY	$2.5 - $3.51 $270,232 - $379,406	108,093 New	108,093 $328,000
Q2 2019 Aug 14, 2019	SELL	$1.46 - $4.44 $79,862 - $242,868	-54,700 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$3.41 - $4.57 $23,610 - $31,642	-6,924 Reduced 11.24%	54,700 $196,000
Q4 2018 Feb 13, 2019	BUY	$3.5 - $9.66 $25,305 - $69,841	7,230 Added 13.29%	61,624 $236,000
Q3 2018 Nov 14, 2018	BUY	$7.85 - $12.35 $2,802 - $4,408	357 Added 0.66%	54,394 $514,000
Q2 2018 Aug 14, 2018	BUY	$5.0 - $7.35 $270,185 - $397,171	54,037 New	54,037 $394,000

Others Institutions Holding ABUS

# of Institutions

138

Shares Held

95.4M

Call Options Held

3.44M

Put Options Held

377K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $591M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account

California State Teachers Retirement System Arbutus Biopharma Corp Transaction History